These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1617157)

  • 1. Enhancement of interleukin 6 cytostatic effect on human breast carcinoma cells by soluble IL-6 receptor from urine and reversion by monoclonal antibody.
    Novick D; Shulman LM; Chen L; Revel M
    Cytokine; 1992 Jan; 4(1):6-11. PubMed ID: 1617157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse plasmacytoma growth in vivo: enhancement by interleukin 6 (IL-6) and inhibition by antibodies directed against IL-6 or its receptor.
    Vink A; Coulie P; Warnier G; Renauld JC; Stevens M; Donckers D; Van Snick J
    J Exp Med; 1990 Sep; 172(3):997-1000. PubMed ID: 2388041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor and interleukin 1 can act as essential growth factors in a murine plasmacytoma line.
    Le J; Reis LF; Vilcek J
    Lymphokine Res; 1988; 7(2):99-106. PubMed ID: 3261383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-6 receptors and sensitivity to growth inhibition by IL-6 in clones of human breast carcinoma cells.
    Chen L; Shulman LM; Revel M
    J Biol Regul Homeost Agents; 1991; 5(4):125-36. PubMed ID: 1803860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A monoclonal antibody specific for the murine IL-6-receptor inhibits the growth of a mouse plasmacytoma in vivo.
    Coulie PG; Vink A; Van Snick J
    Curr Top Microbiol Immunol; 1990; 166():43-6. PubMed ID: 2073815
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-murine IL-6 receptor antibody inhibits IL-6 effects in vivo.
    Suzuki H; Yasukawa K; Saito T; Anzai M; Goitsuka R; Hasegawa A; Ohsugi Y; Taga T; Kishimoto T
    Immunol Lett; 1991 Sep; 30(1):17-21. PubMed ID: 1959939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gp130 in human myeloma/plasmacytoma.
    Tani Y; Nishimoto N; Ogata A; Shima Y; Yoshizaki K; Kishimoto T
    Curr Top Microbiol Immunol; 1995; 194():229-33. PubMed ID: 7895494
    [No Abstract]   [Full Text] [Related]  

  • 8. Epitope peptides from interleukin-6 receptor which inhibit the growth of human myeloma cells.
    Halimi H; Eisenstein M; Oh JW; Revel M; Chebath J
    Eur Cytokine Netw; 1995; 6(3):135-43. PubMed ID: 8589270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-6 receptor-interleukin-6 fusion proteins with enhanced interleukin-6 type pleiotropic activities.
    Chebath J; Fischer D; Kumar A; Oh JW; Kolett O; Lapidot T; Fischer M; Rose-John S; Nagler A; Slavin S; Revel M
    Eur Cytokine Netw; 1997 Dec; 8(4):359-65. PubMed ID: 9459615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-6 inhibits the chemotaxis of human malignant plasma cell lines.
    Shibayama H; Tagawa S; Hattori H; Harigaya K; Taga T; Machii T; Kitani T
    Br J Haematol; 1996 Jun; 93(3):534-41. PubMed ID: 8652370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody.
    McIntyre KW; Stepan GJ; Kolinsky KD; Benjamin WR; Plocinski JM; Kaffka KL; Campen CA; Chizzonite RA; Kilian PL
    J Exp Med; 1991 Apr; 173(4):931-9. PubMed ID: 1826128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of 5B12.1, a monoclonal antibody specific for IL-6.
    Sawamura M; Everson MP; Shrestha K; Ghanta VK; Miller DM; Hiramoto RN
    Growth Factors; 1990; 3(3):181-90. PubMed ID: 2245041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies to the soluble human IL-6 receptor: affinity purification, ELISA, and inhibition of ligand binding.
    Novick D; Engelmann H; Revel M; Leitner O; Rubinstein M
    Hybridoma; 1991 Feb; 10(1):137-46. PubMed ID: 2032732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trophoblast-derived tumor necrosis factor-alpha induces release of human chorionic gonadotropin using interleukin-6 (IL-6) and IL-6-receptor-dependent system in the normal human trophoblasts.
    Li Y; Matsuzaki N; Masuhiro K; Kameda T; Taniguchi T; Saji F; Yone K; Tanizawa O
    J Clin Endocrinol Metab; 1992 Jan; 74(1):184-91. PubMed ID: 1727819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a major 50-kDa molecular weight human B-cell growth factor with Tac antigen-inducing activity on B cells.
    Kawano M; Matsushima K; Oppenheim JJ
    Cell Immunol; 1987 Aug; 108(1):132-49. PubMed ID: 3111722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncostatin M, leukemia inhibitory factor, and interleukin 6 induce the proliferation of human plasmacytoma cells via the common signal transducer, gp130.
    Nishimoto N; Ogata A; Shima Y; Tani Y; Ogawa H; Nakagawa M; Sugiyama H; Yoshizaki K; Kishimoto T
    J Exp Med; 1994 Apr; 179(4):1343-7. PubMed ID: 8145046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular hyperplasia, plasmacytoma formation, and extramedullary hematopoiesis in interleukin (IL)-6/soluble IL-6 receptor double-transgenic mice.
    Schirmacher P; Peters M; Ciliberto G; Blessing M; Lotz J; Meyer zum Büschenfelde KH; Rose-John S
    Am J Pathol; 1998 Aug; 153(2):639-48. PubMed ID: 9708822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant interleukin 2 or 5, but not 3 or 4, induces maturation of resting mouse B lymphocytes and propagates proliferation of activated B cell blasts.
    Karasuyama H; Rolink A; Melchers F
    J Exp Med; 1988 Apr; 167(4):1377-90. PubMed ID: 3128631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A soluble interleukin 6 receptor isolated from conditioned medium of human breast cancer cells is encoded by a differentially spliced mRNA.
    Oh JW; Revel M; Chebath J
    Cytokine; 1996 May; 8(5):401-9. PubMed ID: 8726669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the interleukin 6 signal transducer gp130.
    Taga T; Narazaki M; Yasukawa K; Saito T; Miki D; Hamaguchi M; Davis S; Shoyab M; Yancopoulos GD; Kishimoto T
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10998-1001. PubMed ID: 1438305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.